Organigram Holdings Inc. Net Debt/EBITDA

Net Debt/EBITDA of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Debt/EBITDA growth rates and interactive chart.


Highlights and Quick Summary

  • Net Debt/EBITDA for the quarter ending August 31, 2022 was 26.65 (a 165.26% increase compared to previous quarter)
  • Year-over-year quarterly Net Debt/EBITDA increased by 206.12%
  • Annual Net Debt/EBITDA for 2022 was 5.39 (a 147.97% increase from previous year)
  • Annual Net Debt/EBITDA for 2021 was 2.17 (a -895.06% decrease from previous year)
  • Annual Net Debt/EBITDA for 2020 was -0.27 (a 905.51% increase from previous year)
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Debt/EBITDA of Organigram Holdings Inc.

Most recent Net Debt/EBITDAof OGI including historical data for past 10 years.

Interactive Chart of Net Debt/EBITDA of Organigram Holdings Inc.

Organigram Holdings Inc. Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 26.65 10.05 16.97 5.39
2021 8.71 26.81 9.0 0.52 2.17
2020 0.81 -1.01 -0.43 146.05 -0.27
2019 14.34 -0.07 4.2 -1621.0 -0.03
2018 0.06 -9.62 2.6
2017 3.72
2016 -14.4

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic